No cases of potassium levels exceeding 6.0 mmol/L were observed.

Swiss pharma major Novartis (NOVN: VX) is set to lay off 427 employees at its East Hanover, New Jersey, site as part of a ...

This prospective cohort study first presented evidence for clinical use of an angiotensin receptor blocker in pediatric pulmonary vein stenosis. We evaluated the novel use of valsartan to attenuate ...

A substudy of the VANISH randomized clinical trial, published March 5 in JAMA Cardiology, identified potential benefit of valsartan for cardiac remodeling and indexed intracellular volume in patients ...

Several previous analytical methods have been reported for the determination of sacubitril and valsartan in rat plasma using liquid chromatography (LC) with fluorescence detector 10 and liquid ...

Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.

Novartis markets and sells a combination therapy of valsartan and sacubitril under the brand name Entresto® for the treatment of various forms ...

Even as Novartis takes home a partial win in court tied to its key blockbuster Entresto, the Swiss drugmaker continues to ...

Novartis said that the latest round of job losses is a result of a change in focus for its cardiovascular teams as they lower the emphasis on Entresto and devote more resources to its twice-yearly ...

Discover the life-extending approaches to managing heart failure through medication adherence, lifestyle modifications, and ...